AACC2022

Ebe ntu763 

Chicago26-28Julaị 2022

JTeknụzụ NKE OINSTAR BIOMEDICALCO.LTD., nwere obi ụtọ ịkpọsa anyị nsonye naAACCIhe ngosi na Chicago afọ a.

Obi ga-adị anyị ụtọ izute gị n'ụlọ ntu anyị Ọ bụrụ na ị na-eme atụmatụ ịga ihe ngosi nke afọ a.

JOINSTARisotu n'ime ndị nrụpụta Point-of-Care na China nwere ihe karịrị 25 nyocha dabere na teknụzụ nyocha Dry Immunofluorescence.Pọtụfoliyo ngwaahịa anyị buru ibu na-ekpuchi mpaghara ọrịa dịka Iọrịa njes, Ọrịa obi, Ọrịa akụrụ, ahụike ọmụmụ wdg. Joinstar bụ onye na-agba ọsọ n'ihu na njikwa nke Sepsis yana ịnweta ule POCT maka biomarker akwụkwọ akụkọ nwere ikike, Heparin Binding Protein (HBP).Egosiputara biomarker akwụkwọ akụkọ a ka ọ bụrụ ihe ngosipụta prognostic ka mma na sepsis ma e jiri ya tụnyere ule ndị ama ama ugbu a.Na mgbakwunye na HBP, Joinstar bụ naanị ụlọ ọrụ na-etinye panel Sepsis zuru ezu na akwụkwọ akụkọ ya, gụnyere ule maka PCT na IL-6.N'oge ọrịa Covid 19 na-adịbeghị anya, nyocha ndị a, ọkachasị HBP, egosila na ọ bụ isi na njikwa ọrịa yana data na nso nso a sitere na ọtụtụ mbipụta na-egosi naHBP nwere ike ibu amụma ọdịda iku ume yana ụbọchị 28 ga-anwụ na ndị ọrịa COVID-19na bụkwaanihe ize ndụ nke onwe maka ịnwụ anwụ)   

Maka ozi ndị ọzọ, biko kpọtụrụusozugbo ma ọ bụ gaa na webụsaịtị anyị: https://www.joinstar.com/jet-istar-platform/

maka ozi kọntaktị, bikoemail ka:info@joinstar.cn-we na-atụ anya ịnụ gị, na ịtụ anya ịhụ gị na Chicago!Bịa hụ anyị, n'ụlọ ntu Joinstar#763ma mụta banyere ngwaahịa na ngwa anyị niile na-atọ ụtọ.